Formulation Development

PEPTIDE DELIVERY – The Endometriosis Enigma – Why Can’t There Be a Pill for That?

Joel Tune, MBA, says for those peptide therapeutics that meet the necessary criteria, advances in formulation technologies coupled with favorable market dynamics will continue to drive interest across the entire prescription drug spectrum for safe and effective orally administered peptide therapeutics.

EXCLUSIVE ONLINE CONTENT

WEBINARS

WHITE PAPERS